Literature DB >> 32087570

Role of Apelin/APJ axis in cancer development and progression.

Javad Masoumi1, Abdollah Jafarzadeh2, Hossein Khorramdelazad3, Morteza Abbasloui4, Jalal Abdolalizadeh5, Najmeh Jamali6.   

Abstract

Apelin is an endogenous peptide, which is expressed in a vast board of organs such as the brain, placenta, heart, lungs, kidneys, pancreas, testis, prostate and adipose tissues. The apelin receptor, called angiotensin-like-receptor 1 (APJ), is also expressed in the brain, spleen, placenta, heart, liver, intestine, prostate, thymus, testis, ovary, lungs, kidneys, stomach, and adipose tissue. The apelin/APJ axis is involved in a number of physiological and pathological processes. The apelin expression is increased in various kinds of cancer and the apelin/APJ axis plays a key role in the development of tumors through enhancing angiogenesis, metastasis, cell proliferation and also through the development of cancer stem cells and drug resistance. The apelin also stops the apoptosis of cancer cells. The apelin/APJ axis was considered in this review as an attractive therapeutic target for cancer treatment.
Copyright © 2020 Medical University of Bialystok. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Apelin; Cancer; Therapeutic potentials

Mesh:

Substances:

Year:  2020        PMID: 32087570     DOI: 10.1016/j.advms.2020.02.002

Source DB:  PubMed          Journal:  Adv Med Sci        ISSN: 1896-1126            Impact factor:   3.287


  11 in total

Review 1.  The pleiotropic roles of adipocyte secretome in remodeling breast cancer.

Authors:  Xiaomei Zhou; Jun Zhang; Wenchang Lv; Chongru Zhao; Yu Xia; Yiping Wu; Qi Zhang
Journal:  J Exp Clin Cancer Res       Date:  2022-06-14

2.  Evaluation of Apelin/APJ system expression in hepatocellular carcinoma as a function of clinical severity.

Authors:  Manuela Cabiati; Melania Gaggini; Paolo De Simone; Silvia Del Ry
Journal:  Clin Exp Med       Date:  2020-11-17       Impact factor: 3.984

Review 3.  The Adipokines in Cancer Cachexia.

Authors:  Michele Mannelli; Tania Gamberi; Francesca Magherini; Tania Fiaschi
Journal:  Int J Mol Sci       Date:  2020-07-09       Impact factor: 5.923

Review 4.  Another Weapon against Cancer and Metastasis: Physical-Activity-Dependent Effects on Adiposity and Adipokines.

Authors:  Silvia Perego; Veronica Sansoni; Ewa Ziemann; Giovanni Lombardi
Journal:  Int J Mol Sci       Date:  2021-02-18       Impact factor: 5.923

Review 5.  Study Progression of Apelin/APJ Signaling and Apela in Different Types of Cancer.

Authors:  Longfei Liu; Xiaoping Yi; Can Lu; Yong Wang; Qiao Xiao; Liang Zhang; Yingxian Pang; Xiao Guan
Journal:  Front Oncol       Date:  2021-04-12       Impact factor: 6.244

6.  Loss of MAGEC3 Expression Is Associated with Prognosis in Advanced Ovarian Cancers.

Authors:  James Ellegate; Michalis Mastri; Emily Isenhart; John J Krolewski; Gurkamal Chatta; Eric Kauffman; Melissa Moffitt; Kevin H Eng
Journal:  Cancers (Basel)       Date:  2022-01-30       Impact factor: 6.639

7.  Establishment and Analysis of an Individualized Immune-Related Gene Signature for the Prognosis of Gastric Cancer.

Authors:  Mengying Li; Wei Cao; Bingqian Huang; Zhipeng Zhu; Yaxin Chen; Jiawei Zhang; Guodong Cao; Bo Chen
Journal:  Front Surg       Date:  2022-01-31

Review 8.  Thromboinflammatory Processes at the Nexus of Metabolic Dysfunction and Prostate Cancer: The Emerging Role of Periprostatic Adipose Tissue.

Authors:  Ibrahim AlZaim; Aya Al-Saidi; Safaa H Hammoud; Nadine Darwiche; Yusra Al-Dhaheri; Ali H Eid; Ahmed F El-Yazbi
Journal:  Cancers (Basel)       Date:  2022-03-25       Impact factor: 6.639

9.  Inhibition of APLN suppresses cell proliferation and migration and promotes cell apoptosis in esophageal cancer cells <em>in vitro</em>, through activating PI3K/mTOR signaling pathway.

Authors:  Yuhan Wang; Gang Wang; Xiaojun Liu; Dong Yun; Qing Cui; Xiaoting Wu; Wenfeng Lu; Xiwen Yang; Ming Zhang
Journal:  Eur J Histochem       Date:  2022-08-03       Impact factor: 1.966

10.  Data mining of key genes expression in hepatocellular carcinoma: novel potential biomarkers of diagnosis prognosis or progression.

Authors:  Manuela Cabiati; Melania Gaggini; Paolo De Simone; Silvia Del Ry
Journal:  Clin Exp Metastasis       Date:  2022-04-16       Impact factor: 4.510

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.